Tivic Health Systems, Inc. (TIVC)

Tivic Health Systems, Inc. (TIVC) stock has experienced a significant decline in the past six months. The stock price has decreased by 75.29% over the last six months and 42.35% in the past month. As of February 5, 2026, the stock traded at $0.83, with a market capitalization of $1.47 million. The 52-week high was $15.65, and the 52-week low was $0.78. The company reported a GAAP EPS of -$1.48 and revenue of $0.28 million for Q3 2023, missing revenue estimates by $0.5 million. Tivic Health is currently unprofitable, and its losses have increased over the past five years.

Information regarding demand seasonality for Tivic Health Systems, Inc.'s products and services is not available in the provided search results.

Tivic Health Systems, Inc. is a bio-electronic health-tech company focused on microcurrent therapy solutions for chronic diseases. Their primary product is ClearUP Sinus Relief, an FDA-cleared device for alleviating sinus pain and congestion. The company is pivoting to become a diversified immunotherapeutics company, advancing drug product candidates like Entolimod™ for Acute Radiation Syndrome. Tivic Health also owns Velocity Bioworks, a contract development and manufacturing organization.

Tivic Health Systems, Inc. is headquartered in Fremont, California. The company primarily focuses on the United States for its bio-electronic device, selling ClearUP directly to consumers through its websites and platforms like Amazon.com and Walmart.com, and distributing to U.S. online retailers like BestBuy and FSAStore.

Information specifically detailing Tivic Health Systems, Inc.'s brand reputation or any events that have significantly affected it in the past year is not readily available in the provided search results.

Tivic Health Systems, Inc. has low institutional ownership, approximately 4.25% of the stock. The majority of the stock, over 95%, is held by individual retail investors. There are 10 institutional owners and shareholders who have filed 13D/G or 13F forms with the SEC, holding a total of 203,318 shares. Major institutional shareholders include Lasry Marc, DRW Securities, LLC, Marex Group plc, FSMAX - Fidelity Extended Market Index Fund, VEXMX - Vanguard Extended Market Index Fund Investor Shares, Citigroup Inc., UBS Group AG, FCFMX - Fidelity Series Total Market Index Fund, SBI Securities Co., Ltd., and Bank Of America Corp /de/.